INS and preeclampsia: Methylation presence has been identified among women with preeclampsia [39], and in cord blood [40], which could decrease the numbers of stem cells involved in islet cell development, with an increased risk for abnormal insulin secretion, resistance to insulin, and type 2 diabetes in offspring [39].